About Novavax, Inc.
Novavax is a biotech focused on protein-based COVID and flu vaccines. Highly volatile and speculative, driven by regulatory decisions, partnership news, and revenue uncertainty. No dividend. CSP premiums are rich from sky-high IV, but binary event risk is severe — suitable only for aggressive, event-aware sellers comfortable with large gaps.
Biotechnology